RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 118 filers reported holding RELMADA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $97,635 | +22.0% | 32,545 | 0.0% | 0.00% | +33.3% |
| Q2 2023 | $80,061 | +8.8% | 32,545 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $73,552 | -35.2% | 32,545 | 0.0% | 0.00% | -40.0% |
| Q4 2022 | $113,582 | -90.6% | 32,545 | 0.0% | 0.01% | -91.1% |
| Q3 2022 | $1,205,000 | +95.0% | 32,545 | 0.0% | 0.06% | +107.4% |
| Q2 2022 | $618,000 | -29.6% | 32,545 | 0.0% | 0.03% | -20.6% |
| Q1 2022 | $878,000 | +19.8% | 32,545 | 0.0% | 0.03% | +25.9% |
| Q4 2021 | $733,000 | -1.5% | 32,545 | +14.7% | 0.03% | -12.9% |
| Q3 2021 | $744,000 | -18.1% | 28,378 | 0.0% | 0.03% | -13.9% |
| Q2 2021 | $908,000 | -9.1% | 28,378 | 0.0% | 0.04% | -12.2% |
| Q1 2021 | $999,000 | -30.9% | 28,378 | -37.0% | 0.04% | -36.9% |
| Q4 2020 | $1,445,000 | +35.3% | 45,044 | +58.7% | 0.06% | +20.4% |
| Q3 2020 | $1,068,000 | -15.9% | 28,378 | 0.0% | 0.05% | -20.6% |
| Q2 2020 | $1,270,000 | +31.2% | 28,378 | 0.0% | 0.07% | +15.3% |
| Q1 2020 | $968,000 | -18.3% | 28,378 | -6.6% | 0.06% | +3.5% |
| Q4 2019 | $1,185,000 | – | 30,378 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |